Rekah Pharmaceutical Industries Overview

  • Year Founded
  • 1941

Year Founded

  • Status
  • Public

  • Employees
  • 455

Employees

  • Stock Symbol
  • REKA

Stock Symbol

  • Share Price
  • $3.73
  • (As of Thursday Closing)

Rekah Pharmaceutical Industries General Information

Description

Rekah Pharmaceutical Prod Ltd is engaged in the manufacturing, importing, marketing, and distribution of pharmaceuticals and cosmetics. It primarily caters to the needs of hospitals, retirement homes, and national medical healthcare services.

Contact Information

Website
www.rekah.co.il
Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Other Industries
Distributors/Wholesale
Stock Exchange
TAE
Corporate Office
  • Post Office Box 25
  • Azor 5819001
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Rekah Pharmaceutical Industries Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.73 $3.79 $3.38 - $5.26 $42.6M 11.4M 1.44K -$0.16

Rekah Pharmaceutical Industries Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 88,020 88,020 90,293 132,930
Revenue 86,820 86,820 86,938 81,496
EBITDA 8,218 8,218 9,943 11,157
Net Income (1,865) (1,865) (607) 2,045
Total Assets 127,682 127,682 127,247 140,665
Total Debt 48,378 48,378 43,807 53,366
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rekah Pharmaceutical Industries Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Rekah Pharmaceutical Industries‘s full profile, request access.

Request a free trial

Rekah Pharmaceutical Industries Executive Team (4)

Name Title Board Seat Contact Info
Mordechai Elgrabli Chairman, President & Chief Executive Officer
Yuval Bernshtein Chief Financial Officer
Chaim Cohen Chief Accounting Officer
You’re viewing 3 of 4 executive team members. Get the full list »

Rekah Pharmaceutical Industries Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Rekah Pharmaceutical Industries Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Rekah Pharmaceutical Industries‘s full profile, request access.

Request a free trial

Rekah Pharmaceutical Industries ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Rekah Pharmaceutical Industries’s complete esg history, request access »

Rekah Pharmaceutical Industries FAQs

  • When was Rekah Pharmaceutical Industries founded?

    Rekah Pharmaceutical Industries was founded in 1941.

  • Who is the CEO of Rekah Pharmaceutical Industries?

    Mordechai Elgrabli is the CEO of Rekah Pharmaceutical Industries.

  • Where is Rekah Pharmaceutical Industries headquartered?

    Rekah Pharmaceutical Industries is headquartered in Azor, Israel.

  • What is the size of Rekah Pharmaceutical Industries?

    Rekah Pharmaceutical Industries has 455 total employees.

  • What industry is Rekah Pharmaceutical Industries in?

    Rekah Pharmaceutical Industries’s primary industry is Pharmaceuticals.

  • Is Rekah Pharmaceutical Industries a private or public company?

    Rekah Pharmaceutical Industries is a Public company.

  • What is Rekah Pharmaceutical Industries’s stock symbol?

    The ticker symbol for Rekah Pharmaceutical Industries is REKA.

  • What is the current stock price of Rekah Pharmaceutical Industries?

    As of 11-Apr-2024 the stock price of Rekah Pharmaceutical Industries is $3.73.

  • What is the current market cap of Rekah Pharmaceutical Industries?

    The current market capitalization of Rekah Pharmaceutical Industries is $42.6M.

  • What is Rekah Pharmaceutical Industries’s current revenue?

    The trailing twelve month revenue for Rekah Pharmaceutical Industries is $86.8M.

  • What is Rekah Pharmaceutical Industries’s annual earnings per share (EPS)?

    Rekah Pharmaceutical Industries’s EPS for 12 months was -$0.16.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »